Podlesak Dennis
Syndax Pharmaceuticals, Inc. · Director
Podlesak Dennis is listed in filings as Director at Syndax Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 6, 2026, including sale activity. Recent filings connect the profile to Syndax Pharmaceuticals, Inc. (SNDX). The current snapshot covers public activity from Feb 7, 2025 to Feb 6, 2026. Reported amounts are shown as $304.2K to $298.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $304k19.2k shares | SellAug 18, 2025 | $15.84 | $22.71 |